title: Suprasellar hemangioblastoma in a patient with von Hippel-Lindau disease confirmed by germline mutation study: case report and review of the literature.
abstract: BACKGROUND
  Hemangioblastoma (HBL) in the suprasellar region is extremely rare.
  
  
  METHODS
  A suprasellar mass was found in a 33-year-old woman with retinal HBL and bilateral adrenal pheochromocytomas. The diagnosis of von Hippel-Lindau (VHL) disease was confirmed preoperatively not only by these clinical manifestations but also by germline mutation study. The existence of VHL disease indicated a diagnosis of HBL for the suprasellar mass. The results of our mutation study indicated that this patient had type II VHL disease, suggesting that careful follow-up is essential for the early detection of renal cell carcinoma, which is often associated with type II VHL disease. Here, we summarize the previously reported features of sellar and suprasellar HBLs.
  
  
  CONCLUSIONS
  HBLs in this region may be one manifestation of VHL disease. Genetic testing of the VHL gene of our patient could provide useful information to determine appropriate medical care and management.
authors.affiliation: Department of Neurosurgery, Kumamoto University School of Medicine, Kumamoto, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Goto
authors.forename: T
authors.initials: T
authors.lastname: Nishi
authors.forename: N
authors.initials: N
authors.lastname: Kunitoku
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: I
authors.initials: I
authors.lastname: Kitamura
authors.forename: H
authors.initials: H
authors.lastname: Takeshima
authors.forename: M
authors.initials: M
authors.lastname: Kochi
authors.forename: Y
authors.initials: Y
authors.lastname: Nakazato
authors.forename: J
authors.initials: J
authors.lastname: Kuratsu
authors.forename: Y
authors.initials: Y
authors.lastname: Ushio
mesh_terms: D000328:Adult; D001483:Base Sequence / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D018095:Germ-Line Mutation / Q000235:genetics*; D018325:Hemangioblastoma / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D006801:Humans; D008025:Ligases / Q000235:genetics; D008279:Magnetic Resonance Imaging; D020125:Mutation, Missense / Q000235:genetics; D010911:Pituitary Neoplasms / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D006623:von Hippel-Lindau Disease / Q000235:genetics* / Q000473:pathology / Q000601:surgery
chemical_list: D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D008025:Ligases; C497446:VHL protein, human